Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : CSTL save search
Castle Biosciences to Release First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 2, 2024
Published: 2024-04-11 (Crawled : 12:00) - biospace.com/
CSTL | $20.02 2.09% 2.05% 200K
|
Health Technology
|
| O: 0.63%
H: 0.82%
C: -0.14%
first conference financial results
Castle Biosciences’ Chief Financial Officer Frank Stokes Recognized as a Top CFO of Houston for Second Consecutive Year
Published: 2024-04-10 (Crawled : 12:00) - biospace.com/
XYF | News | $3.882 -0.46% 0.0% 340
|
Finance
|
| O: -2.11%
H: 2.96%
C: 2.15%
CSTL | $20.02 2.09% 2.05% 200K
|
Health Technology
|
| O: -1.76%
H: 0.0%
C: 0.0%
year for financial
Castle Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-02 (Crawled : 12:00) - biospace.com/
CSTL | $20.02 2.09% 2.05% 200K
|
Health Technology
|
| O: -0.46%
H: 2.72%
C: 2.26%
conference
Castle Biosciences Earns a Top Workplaces USA Award for the Third Consecutive Year
Published: 2024-03-25 (Crawled : 00:00) - biospace.com/
CSTL | $20.02 2.09% 2.05% 200K
|
Health Technology
|
| O: -0.74%
H: 5.82%
C: 3.48%
award year workplaces usa
Vivani Medical Appoints Daniel Bradbury to its Board of Directors
Published: 2024-03-06 (Crawled : 15:30) - biospace.com/
VANI | $1.81 8.38% 7.73% 88K
|
Manufacturing
|
| O: 4.65%
H: 4.44%
C: -1.78%
BMY | $48.99 -0.31% 0.0% 9.1M
|
Health Technology
|
| O: 1.0%
H: 2.81%
C: 1.99%
EQ | $1.77 7.27% 6.78% 88K
|
Health Technology
|
| O: -0.45%
H: 7.35%
C: 1.35%
CSTL | $20.02 2.09% 2.05% 200K
|
Health Technology
|
| O: 1.52%
H: 1.32%
C: -5.25%
medical
Castle Biosciences to Release Fourth Quarter and Full-Year 2023 Financial Results and Host Conference Call on Wednesday, Feb. 28, 2024
Published: 2024-02-07 (Crawled : 13:00) - biospace.com/
CSTL | $20.02 2.09% 2.05% 200K
|
Health Technology
|
| O: 0.79%
H: 1.29%
C: -2.98%
conference financial results
Castle Biosciences’ Chief Operating Officer Kristen Oelschlager Selected Among the Top 25 Women Leaders in Biotechnology by The Healthcare Technology Report
Published: 2024-01-09 (Crawled : 14:00) - biospace.com/
CSTL | $20.02 2.09% 2.05% 200K
|
Health Technology
|
| O: -1.74%
H: 2.72%
C: -2.47%
report women leaders technology
Castle Biosciences Announces Preliminary Fourth Quarter and Full-Year 2023 Results
Published: 2024-01-08 (Crawled : 08:00) - biospace.com/
CSTL | $20.02 2.09% 2.05% 200K
|
Health Technology
|
| O: 0.81%
H: 3.68%
C: 3.31%
results
Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 20, 2023
Published: 2023-12-20 (Crawled : 13:00) - biospace.com/
CSTL | $20.02 2.09% 2.05% 200K
|
Health Technology
|
| O: -0.57%
H: 2.49%
C: -2.29%
nasdaq grants
Castle Biosciences Reports Third Quarter 2023 Results
Published: 2023-11-02 (Crawled : 00:00) - biospace.com/
CSTL | $20.02 2.09% 2.05% 200K
|
Health Technology
|
| O: 2.8%
H: 5.82%
C: 3.16%
results
Persephone Biosciences Appoints Daniel Bradbury as Chair of the Board of Directors
Published: 2023-10-23 (Crawled : 13:00) - biospace.com/
BMY | $48.99 -0.31% 0.0% 9.1M
|
Health Technology
|
| O: -0.19%
H: 0.66%
C: -0.62%
ICPT | $19.0 -0.05% 4M
|
Health Technology
|
| O: -0.16%
H: 0.0%
C: 0.0%
EQ | $1.77 7.27% 6.78% 88K
|
Health Technology
|
| O: 1.16%
H: 3.28%
C: -2.68%
CSTL | $20.02 2.09% 2.05% 200K
|
Health Technology
|
| O: 0.0%
H: 1.87%
C: 0.0%
Castle Biosciences to Release Third Quarter 2023 Financial Results and Host Conference Call on Thursday, Nov. 2
Published: 2023-10-19 (Crawled : 12:30) - biospace.com/
CSTL | $20.02 2.09% 2.05% 200K
|
Health Technology
|
| O: -0.46%
H: 0.23%
C: -1.23%
conference financial results
New Data Highlights Clinical Utility and Performance of Castle Biosciences’ Dermatologic Test Portfolio at the 2023 Fall Clinical Dermatology Conference®
Published: 2023-10-18 (Crawled : 23:00) - biospace.com/
CSTL | $20.02 2.09% 2.05% 200K
|
Health Technology
|
| O: -0.88%
H: 1.02%
C: -3.2%
conference test
DecisionDx®-Melanoma Outperforms Memorial Sloan Kettering Cancer Center (MSKCC) Nomogram in Predicting Sentinel Lymph Node Positivity in Patients with Cutaneous Melanoma
Published: 2023-10-05 (Crawled : 13:30) - biospace.com/
CSTL | $20.02 2.09% 2.05% 200K
|
Health Technology
|
| O: -0.26%
H: 1.37%
C: -3.32%
decisiondx melanoma cancer sentinel
Castle Biosciences Presents New Data at ASTRO 2023 Highlighting Risk-Stratification Performance of DecisionDx®-SCC in Patients with Cutaneous Squamous Cell Carcinoma Eligible for Adjuvant Radiation Therapy
Published: 2023-10-03 (Crawled : 13:00) - biospace.com/
CSTL | $20.02 2.09% 2.05% 200K
|
Health Technology
|
| O: -0.97%
H: 0.0%
C: -3.81%
decisiondx cell therapy
Castle Biosciences Shares New Data Demonstrating Ability of TissueCypher® Test Results to Inform Clinical Decision-Making in Patients with Non-Dysplastic Barrett’s Esophagus
Published: 2023-10-02 (Crawled : 17:00) - biospace.com/
CSTL | $20.02 2.09% 2.05% 200K
|
Health Technology
|
| O: -0.3%
H: 0.0%
C: -2.43%
tissuecypher test results
Castle Biosciences, Leading Skin Cancer Expert, Darrell Rigel, M.D., M.S., and IMPACT Melanoma Board Member to Ring Nasdaq Closing Bell on Sept. 27, 2023, to Raise Awareness of Melanoma
Published: 2023-09-25 (Crawled : 12:00) - biospace.com/
CSTL | $20.02 2.09% 2.05% 200K
|
Health Technology
|
| O: 0.85%
H: 0.0%
C: -0.84%
melanoma nasdaq bell cancer impact skin
Precision Medicine Takes Center Stage: Innovative Report Explores the Role of Companion Diagnostics in Transforming Healthcare
Published: 2023-09-22 (Crawled : 22:00) - prnewswire.com
MLAB | $106.92 4.56% 4.36% 34K
|
Health Technology
| Email alert
Add to watchlist
ANPCF | News | $0.148 641.22% 5K
|
Health Technology
| Email alert
Add to watchlist
NH | $1.35 -46.64% -1.48% 0
|
Technology Services
| Email alert
Add to watchlist
BIOC | $0.4349 -10.32% 750K
|
Health Services
| Email alert
Add to watchlist
NVTA | News | $0.019 0.0% 22M
|
Health Services
| Email alert
Add to watchlist
TMO | News | $574.59 4.78% -1.12% 2.5M
|
Health Technology
| Email alert
Add to watchlist
ABT | News | $107.59 0.49% -0.09% 3.8M
|
Health Technology
| Email alert
Add to watchlist
CSTL | $20.02 2.09% 2.05% 200K
|
Health Technology
| Email alert
Add to watchlist
BDX | $234.36 0.21% 0.0% 800K
|
Health Technology
| Email alert
Add to watchlist
NHIQ | $0.3869 16.76% 790
|
Information
| Email alert
Add to watchlist
ANPCY | News | $1.98 338.38% 930
|
Manufacturing
| Email alert
Add to watchlist
TXG | $27.56 -0.86% -0.87% 2M
|
Health Technology
| Email alert
Add to watchlist
report companion diagnostics
TissueCypher® Barrett’s Esophagus Test Outperformed Standard of Care in Risk-Stratifying Patients with Barrett’s Esophagus
Published: 2023-09-14 (Crawled : 13:00) - biospace.com/
CSTL | $20.02 2.09% 2.05% 200K
|
Health Technology
|
| O: 0.54%
H: 0.89%
C: -5.43%
tissuecypher test care
Castle Biosciences Announces Receipt of New York Laboratory Permit for Pittsburgh Laboratory
Published: 2023-09-12 (Crawled : 12:00) - biospace.com/
CSTL | $20.02 2.09% 2.05% 200K
|
Health Technology
|
| O: -0.59%
H: 0.92%
C: -2.14%
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.